Antifungal Activity of Almond (Prunus amygdalus) Hull Extracts against Clinical Isolates of Candida albicans

Document Type : Original Articles

Authors

1 Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Medical Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

3 Core Research Facilities (CRF), Isfahan University of Medical Sciences, Isfahan

4 Department of Medical Parasitology and Mycology, School of Medicine, Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

10.22034/cmm.2024.345245.1545

Abstract

Background and Purpose: Various efforts have been conducted to find potent and effective alternatives with natural origin and lesser side effects for the current antifungals. Here the antifungal effects of the Hydroalcoholic Extract (HE) and Lyophilized Extract (LE) of Prunus amygdalus hulls on clinical isolates of Candida albicans were determined and compared with the fluconazole antifungal.
Material and methods: Following the preparation of botanical compounds, the toxicity, cell viability, and high-performance liquid chromatography (HPLC) of phenolic compounds analyses were assayed. The broth microdilution method was applied to determine the minimum inhibitory concentration (MIC) values of fluconazole, LEs, and HEs against clinical isolates of C. albicans.
Results: According to the HPLC results, the HEs and LEs comprised the main nine components, of which chlorogenic and tannic acids were the most abundant compounds. The results of the toxicity assays revealed that no dilution of the extract was toxic to the cells, and the percentage of cell viability was similar to the control and above 90% in all dilutions. All isolates showed susceptibility to fluconazole (MIC range: 0.12 to 1 μg/mL). The MIC geometric mean (GM) of C. albicans isolates was 0.29 μg/mL, 11.47 μg/mL, and 48.50 μg/mL for fluconazole, LE, and HE, respectively.
Conclusion: Due to their insignificant side effects and cost-effectiveness, these extracts can be introduced as effective antifungals. Further, in-vivo studies and clinical trials should support the study results.

Keywords

Main Subjects



Articles in Press, Accepted Manuscript
Available Online from 30 November 2024
  • Receive Date: 08 June 2024
  • Revise Date: 19 November 2024
  • Accept Date: 30 November 2024
  • Publish Date: 30 November 2024